Electron microscope studies revealedthat 6-hydroxydopamine (6-HODA) destroyed the aminergic (type ‘B’) neurosecretory axons entering the rostral pars distalis of the teleost Tilapia mossambica. 6-HODA had no effect upon plasma sodium or pituitary prolactin levels in seawater (SW) fish, although it prevented the fall in plasma sodium levels normally associated with transfer to fresh water (FW). Furthermore, the prolactin cells of 6-HODA-treated fish transferred to FW were activated as judged by ultrastructural and physiological criteria. These observations lead us to suggest that neurosecretory axons of hypothalamic origin and plasma osmolality interact to regulate teleost prolactin cells. On the other hand, 6-HODA evoked no obvious ultrastructural changes in the ACTH cells and no significant alterations in plasma cortisol concentrations. Thus, it would appear that type ‘B’ axons do not provide the major control of ACTH secretion in Tilapia.

Keywords:
Hypothalamo-pituitary axis, ACTH, Prolactin, Teleost (Tilapia), 6-Hydroxydopamine (6-HODA), Electron microscope
This content is only available via PDF.
© 1974 S. Karger AG, Basel
1973
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.